Fig. 4

Estimated mean change in (a) procollagen type 1 N-terminal propeptide (P1NP) and (b) tartrate-resistant acid phosphatase isoform 5b (TRACP-5b). Error bars represent 95% confidence intervals. *P < 0.001; comparison between the romosozumab and denosumab groups.